Haoxi Health Technology Limited (HAO)
NASDAQ: HAO · IEX Real-Time Price · USD
3.960
-1.010 (-20.32%)
At close: Jul 19, 2024, 4:00 PM
4.220
+0.260 (6.57%)
Pre-market: Jul 22, 2024, 7:14 AM EDT

Company Description

Haoxi Health Technology Limited, through its subsidiaries, provides online marketing solutions in China.

It offers online marketing solutions, including online short video marketing solutions to advertisers through its media partners; and customized marketing solutions by planning, producing, placing, and optimizing online ads to help advertisers acquire, convert, and retain consumers on various online media platforms.

The company places its ads through mainstream online short video and social media platforms, such as Toutiao, Douyin, WeChat, and Sina Weibo.

It serves advertiser client base primarily in the healthcare industry. The company was founded in 2018 and is based in Beijing, China.

Haoxi Health Technology Limited
Haoxi Health Technology logo
Country China
Founded 2018
IPO Date Jan 26, 2024
Industry Advertising Agencies
Sector Communication Services
Employees 32
CEO Zhen Fan

Contact Details

Address:
801/802, Tower C, Building 103, Huizhongli, Chaoyang District
Beijing, F4 100101
China
Phone 86-10-13311587976
Website haoximedia.com

Stock Details

Ticker Symbol HAO
Exchange NASDAQ
Fiscal Year July - June
Reporting Currency USD
IPO Price $4.00
CIK Code 0001954594
CUSIP Number 73936Q629
ISIN Number KYG4290F1000
SIC Code 7311

Key Executives

Name Position
Zhen Fan CEO, Director, and Chairman of the Board of Directors
Lei Xu Chief Operating Officer and Director Appointee
Bo Lyu Chief Financial Officer

Latest SEC Filings

Date Type Title
Jul 18, 2024 F-1/A [Amend] Registration statement for certain foreign private issuers
Jul 15, 2024 F-1/A [Amend] Registration statement for certain foreign private issuers
Jun 13, 2024 F-1 Registration statement for certain foreign private issuers
May 31, 2024 6-K Report of foreign issuer
May 7, 2024 6-K Report of foreign issuer
May 3, 2024 6-K Report of foreign issuer
Mar 15, 2024 DRS [Cover] Draft Registration Statement
Mar 8, 2024 6-K Report of foreign issuer
Jan 30, 2024 6-K Report of foreign issuer
Jan 29, 2024 424B4 Prospectus